Remote Credentialing and Supervision in Respiratory Labs: Regulatory Frameworks for Offsite PFT Review and Sign-Off in 2026
Feb 20, 2026

Remote credentialing and offsite sign-off for pulmonary function testing (PFT) is now a legitimate, regulatory-supported model in many healthcare jurisdictions. In 2026, respiratory labs can operate with credentialed physicians and scientists reviewing and authorising results from a separate location, provided they meet the applicable compliance, documentation, and supervision standards. The infrastructure to support this model, including cloud-based reporting platforms, has matured significantly, making remote oversight both practical and auditable.
TL;DR
Remote credentialing for respiratory lab sign-off is regulatory-supported but requires strict documentation and compliance frameworks.
FDA and CMS have both updated guidance on remote oversight and laboratory personnel requirements in recent years.
Telemedicine credentialing principles apply directly to offsite PFT review workflows.
Technology platforms that are cloud-native and vendor-neutral are central to making remote supervision work reliably.
Rezibase supports offsite sign-off workflows natively, giving labs a compliant, auditable path to remote operations.
What Does "Remote Credentialing" Actually Mean for Respiratory Labs?
Remote credentialing is the process of verifying and granting clinical privileges to a practitioner who will deliver or supervise care from a location separate from the patient or testing site. In the context of respiratory labs, this means a credentialed physician or respiratory scientist can review PFT results, apply clinical interpretation, and formally sign off on reports without being physically present in the lab.
This is distinct from simply emailing a PDF. A compliant remote sign-off workflow requires:
Verified practitioner credentials linked to a specific site or network
Secure, auditable access to raw test data and waveforms
A documented chain of review and authorisation
Alignment with relevant laboratory accreditation standards (e.g., NATA/ISO 15189 in Australia, UKAS in the UK)
According to Andros, telemedicine providers must undergo a specialised process that addresses the unique challenges and considerations associated with delivering care remotely. The same logic applies to any clinician signing off diagnostic results from an offsite location.
What Regulatory Frameworks Govern Offsite PFT Sign-Off in 2026?
Three overlapping regulatory layers typically apply, depending on jurisdiction.
1. Laboratory Personnel and Supervision Standards
In the United States, the Clinical Laboratory Improvement Amendments (CLIA) govern who can supervise and sign off laboratory results. In early 2025, CMS implemented the first major updates to laboratory personnel requirements under Subpart M of CLIA in 30 years. These updates clarified competency assessment requirements and supervision roles, with implications for any lab operating with offsite medical directors or technical supervisors.
2. Remote Regulatory Assessment Guidance
The FDA published final guidance on conducting remote regulatory assessments in June 2025, addressing how regulated facilities can be evaluated without an in-person inspection. While primarily directed at manufacturers and clinical trial sites, the principles around documentation integrity, remote access controls, and audit trails apply broadly to any lab seeking to demonstrate compliance in a distributed model.
3. Accreditation Standards
For Australian and UK labs, accreditation under ISO 15189 (via NATA or UKAS) requires documented procedures for all review and authorisation steps. Remote sign-off is permissible under these frameworks, but only when the system of record can demonstrate who reviewed what, when, and under what credentials.
Jurisdiction | Relevant Framework | Key Requirement for Remote Sign-Off |
|---|---|---|
Australia | NATA / ISO 15189 | Documented authorisation trail, competency records |
United Kingdom | UKAS / NHS Standards | Credentialed practitioner, secure access, audit log |
United States | CLIA / CMS | Qualified supervisor, competency assessment, documentation |
Clinical Trials | FDA Remote Assessment Guidance | Data integrity, access controls, remote audit capability |
How Did the Pandemic Reshape Remote Supervision Norms?
The COVID-19 pandemic accelerated the adoption of remote clinical oversight models that had previously been considered impractical. A 2022 paper published in Trials (Springer Nature) examined the pandemic as a catalyst for regulatory innovation in clinical research, noting that fit-for-purpose approaches to remote oversight gained rapid regulatory acceptance. The authors found this interesting as it demonstrated that regulators could adapt frameworks quickly when clinical necessity demanded it.
The lasting impact is that remote supervision is no longer a workaround. It is now a recognised operational model that regulators have frameworks to assess and approve.
What Are the Practical Steps to Set Up a Compliant Remote Sign-Off Workflow?
Setting up remote PFT sign-off is more straightforward than many labs assume. The key is treating it as a documentation and access control problem, not a clinical one.
Step 1: Confirm Practitioner Credentials and Privileges
According to myeMED Management, the first step in streamlining the credentialing process is gathering all necessary documents required by the credentialing organisation. For remote sign-off, this includes:
Current registration and licence details
Scope of practice documentation
Site-specific privilege approval from the relevant health service
Step 2: Establish Secure, Role-Based Access
The reviewing practitioner needs access to complete test data, not just a summary. This means flow-volume loops, raw spirometry traces, and any technologist notes. Access must be role-based, logged, and revocable.
Step 3: Define the Review and Authorisation Workflow
Document exactly what steps occur between test completion and report authorisation. Who reviews first? What triggers escalation? How is the final sign-off recorded? This workflow must be captured in your quality management system.
Step 4: Maintain an Audit Trail
Every action taken on a report, including who viewed it, who edited it, and who signed it off, must be time-stamped and stored. This is non-negotiable for accreditation compliance.
Step 5: Align with Your Accreditation Body
Before going live, confirm your remote workflow with your accreditation body. Most will accept remote sign-off provided the documentation framework is solid.
What Role Does Technology Play in Making Remote Sign-Off Work?
Technology is the enabler, but the wrong technology creates more risk than it solves. A platform built for remote respiratory reporting needs to handle:
Direct import of device data (not manual re-entry)
Structured reporting aligned to ATS guidelines
Configurable normal values libraries
Role-based access with full audit logging
Cloud-native delivery so access is consistent regardless of location
This is where platforms like Rezibase become relevant. Built by respiratory scientists and delivered as a cloud-based SaaS solution, Rezibase supports offsite PFT review natively. Its Magic Import function pulls discrete data directly from testing devices, eliminating transcription errors that would undermine the integrity of a remote sign-off. The platform's accreditation module is built around ISO 15189 and TSANZ/NATA standards, meaning the audit trail and document management required for remote compliance are built in, not bolted on.
Frequently Asked Questions
Can a respiratory physician sign off PFT reports from home?
Yes, provided they hold the appropriate credentials for the site, have secure access to the full test record, and the sign-off is captured in an auditable system.
Does remote sign-off affect accreditation status?
Not if the workflow is properly documented and the system of record meets accreditation requirements. Most accreditation bodies accept remote authorisation under ISO 15189 frameworks.
What is the difference between remote credentialing and telehealth credentialing?
Remote credentialing for lab sign-off focuses on diagnostic authorisation privileges. Telehealth credentialing, as described by Andros, addresses direct patient care delivery. The documentation requirements overlap significantly.
Are there specific CMS rules about who can sign off PFT results?
CLIA regulations govern laboratory supervision roles. The 2025 CMS updates clarified competency and supervision requirements, which apply to technical supervisors operating remotely.
How do I migrate existing reports to a cloud platform without losing data?
Modern platforms handle this through structured data migration processes. With Rezibase, the transition from legacy systems is managed as a guided process, keeping historical records intact and accessible from day one.
What happens if a remote sign-off system goes offline?
A cloud-native platform with enterprise-grade infrastructure reduces this risk significantly. Labs should also maintain documented contingency procedures for any system downtime.
Is remote supervision suitable for all PFT test types?
Remote review is appropriate for the vast majority of PFT reporting, including spirometry, diffusion capacity, and lung volumes. Complex cases may warrant direct consultation, but routine sign-off is well-suited to remote workflows.
About Rezibase
Rezibase is Australia's most advanced cloud-based respiratory and sleep reporting platform, built by respiratory scientists for respiratory labs. Trusted by over 35 sites including NHS and NSW Health, Rezibase offers vendor-neutral data import, ATS-aligned reporting, ISO 15189 accreditation support, and enterprise-grade cloud delivery with no lock-in contracts. Learn more at rezibase.com.
Ready to explore how Rezibase supports compliant remote sign-off for your respiratory lab? Visit rezibase.com to book a demo or start a 30-day free trial.
References
Andros. Telemedicine Credentialing Guide for Beginners. https://andros.co/insights/telemedicine-credentialing-guide/
Leyens, L. et al. The COVID-19 pandemic as a catalyst for innovation: a regulatory framework to assess fit-for-purpose innovative approaches in clinical research. https://link.springer.com/article/10.1186/s13063-022-06707-w
McDermott Will and Emery. CMS Implements Major Updates to Lab Personnel Requirements. https://www.mwe.com/insights/cms-implements-first-major-updates-to-lab-personnel-requirements-in-30-years/
FDA. Conducting Remote Regulatory Assessments Questions and Answers. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/conducting-remote-regulatory-assessments-questions-and-answers
myeMED Management. A Step-by-Step Guide to Streamlining the Credentialing Process. https://myemed.net/a-step-by-step-guide-to-streamlining-the-credentialing-process/